Back to search

Article

Clearing the Fog with the Cheung's Regimen: A Case of OTC Glutamatergic Augmentation in a Student with Depression, Somatic Symptoms and Cognitive Dysfunction

2025-12-01

Abstract excerpt

<h4>Background: </h4> Young adults with mood and anxiety disorders often remain hamstrung by "brain-fog," headaches, and other bodily complaints even after standard antidepressants or sedatives take the edge off their mood. An inexpensive OTC oral augmentation stack proposed by Cheung (2025)—dextromethorphan for NMDA blockade, low-dose fluoxetine to slow its metabolism, and piracetam to boost AMPA signalling—may r...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e5a948ec-66ef-552f-b8ea-33edc7353948
DOI
10.20944/preprints202512.0122.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Clearing the Fog with the Cheung's Regimen: A Case of OTC Glutamatergic Augmentation in a Student with Depression, Somatic Symptoms and Cognitive DysfunctionDOI 10.20944/preprints202512.0122.v1
Cheung's Regimen Series: Ultra-Low-Dose Paroxetine as CYP2D6 Inhibitor Enables Safe OTC Glutamatergic Augmentation in a Depressive Patient on LisdexamfetamineSemantic proximity
Inducing BDNF and mTOR-Mediated Synaptogenesis via Oral Agents: A Hypothetical Prophylaxis for Alzheimer’s DiseaseSemantic proximity
Oral NMDA and AMPA Modulation for Refractory Obsessive-Compulsive Symptoms in Bipolar Disorder: A Case Series of Routine Clinical OutcomesSemantic proximity
Pharmacological recruitment of a VTA glutamatergic arousal circuit by the natural product BN3 drives broad-spectrum emergence from general anesthesiaSemantic proximity
Ketamine in severe, highly treatment-resistant depression—a retrospective case study and a perspectiveSemantic proximity
Sublingual Ketamine for Depression and Anxiety: A Retrospective Study of Real-World Clinical OutcomesSemantic proximity
Real-world patient characteristics, treatment patterns, efficacy and safety of intramuscular ketamine treatment: a retrospective cohort studySemantic proximity
Ketamine as an adjunctive therapy for major depression - a randomised controlled pragmatic pilot trial (Karma-Dep Trial)Semantic proximity
Ketamine Reimagined: Distinguishing Psychedelic and Psycholytic Modalities for Next-Generation Therapies.Semantic proximity
The impact of the COVID-19 pandemic on Antidepressant Prescribing with a focus on people with learning disability and autism: An interrupted time-series analysis in England using OpenSAFELY-TPPSemantic proximity
Immediate and Long-Term Electrophysiological Biomarkers of Antidepressant Behavioral Effects After Subanesthetic Ketamine and Medial Prefrontal Cortex Deep Brain Stimulation TreatmentSemantic proximity
Oral esketamine in patients with treatment-resistant depression: a double-blind, randomized, placebo-controlled trial with open-label extensionSemantic proximity
Select a neighboring publication to make it the new centre.